St.Vincent's Hospital

Melbourne, Victoria 3065

2 studies enrolling now · 16 studies all time

What they study most

Abiraterone Acetate, Advanced or Metastatic Solid Tumors, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, B-cell Malignancies, Bradycardia, Carcinoma, Renal Cell, Catecholamine-resistant Hypotension (CRH), Cervical Cancer, Coronary Artery Disease, Coronary Artery Stenosis

Studies at this site

• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors — Recruiting now
• Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. — Completed
• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations — Running, not enrolling
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) — Completed
• Phase III Trial of Sirolimus in IBM — Running, not enrolling
• Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL) — Completed
• Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis — Paused
• Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies — Completed
• ImageReady(TM) MR Conditional Pacing System Clinical Study — Completed
• A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed
• SPIRIT PRIME Clinical Trial — Completed
• A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass — Stopped early